Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Henry Schein's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Henry Schein's 5-Year Yield-on-Cost % or its related term are showing as below:
MEX:HSIC's 5-Year Yield-on-Cost % is not ranked *
in the Medical Distribution industry.
Industry Median: 3.76 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Henry Schein (MEX:HSIC) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Henry Schein 5-Year Yield-on-Cost % Related Terms
MEX:HSIC vs AHG, ACH, FOCL: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Henry Schein's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Henry Schein's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Henry Schein is calculated as
Henry Schein (MEX:HSIC) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 16, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Henry Schein and its competitors. According to the industry distribution chart, Henry Schein ranks #999999 out of 69 companies in the Medical Distribution industry.
Is Henry Schein's 5-Year Yield-on-Cost % too high?
Henry Schein's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Henry Schein ranks #999999 out of 69 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Henry Schein has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's 5-Year Yield-on-Cost % compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #999999 out of 69 companies for 5-Year Yield-on-Cost %. This places Henry Schein in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.76, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Henry Schein and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Henry Schein (MEX:HSIC) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is MXN1,279.72, compared to a current price of MXN1,325.00 — trading 3.5% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Henry Schein's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Henry Schein (MEX:HSIC), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (MEX:HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of MXN1,325.00 is trading 3.5% above its estimated GF Value™ of MXN1,279.72.
Key valuation signals for MEX:HSIC:
5-Year Yield-on-Cost %: 0.00
GF Value™: MXN1,279.72 vs. price of MXN1,325.00 (3.5% above fair value)
No single metric tells the full story. See the MEX:HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
80GF Score
Get the complete analysis for MEX:HSIC
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:HSIC has been successfully added to your 
